Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia

被引:64
作者
Hwang, H. S. [1 ]
Kwon, J. Y. [1 ]
Kim, M. A. [1 ]
Park, Y. W. [1 ]
Kim, Y. H. [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Gynecol & Obstet, Div Maternal & Fetal Med, Seoul, South Korea
关键词
C-reactive protein; highly sensitive; mean arterial pressure; pre-eclampsia; time to diuresis;
D O I
10.1016/j.ijgo.2007.03.050
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To establish reference values for highly sensitive C-reactive protein (hsCRP) in normal pregnancy and determine whether disease severity could be predicted by serum hsCRP concentration in women with severe pre-eclampsia (PE). Methods: Blood samples were collected from 25 pregnant women with severe PE and 202 healthy pregnant women who were divided into 4 groups by pregnancy duration. Levels of hsCRP were determined by the immunonephelometric method. Mean arterial pressure, time between delivery and diuresis, and mean ratio of systolic to diastolic blood flow velocity in uterine arteries were used as indicators of the severity of PE. Results: The median values of hsCRP in each group were 0.76 mg/L (0. 16-13.61 mg/L), 1.53 mg/L (0.39-20.31 mg/L), 2.08 mg/L (0.50-9.45 mg/L), and 2.28 mg/L (0.44-8.11 mg/L) and showed a trend toward increase. Serum levels of hsCRP were positively correlated with each severity indicator of PE. Conclusions: This study showed that hsCRP levels were positively correlated to pregnancy duration in healthy women and could be used as a severity marker in women with severe PE. (c) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 25 条
[1]  
ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67
[2]  
*AM COLL OBST GYN, 1996, TECHN B AM COLL OBST, V219
[3]   Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy [J].
Belo, L ;
Santos-Silva, A ;
Rocha, S ;
Caslake, M ;
Cooney, J ;
Pereira-Leite, L ;
Quintanilha, A ;
Rebelo, I .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 123 (01) :46-51
[4]   World Health Organization systematic review of screening tests for preeclampsia [J].
Conde-Agudelo, A ;
Villar, J ;
Lindheimer, M .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (06) :1367-1391
[5]   Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia [J].
Djurovic, S ;
Clausen, T ;
Wergeland, R ;
Brosstad, F ;
Berg, K ;
Henriksen, T .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (07) :759-764
[6]   A prospective randomized trial of magnesium sulfate in severe preeclampsia: Use of diuresis as a clinical parameter to determine the duration of postpartum therapy [J].
Fontenot, MT ;
Lewis, DF ;
Frederick, JB ;
Wang, YP ;
Defranco, EA ;
Groome, LJ ;
Evans, AT .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 192 (06) :1788-1793
[7]   C-reactive protein: a serological marker for preterm delivery? [J].
Hvilsom, GB ;
Thorsen, P ;
Jeune, B ;
Bakketeig, LS .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (05) :424-429
[8]   Lipid peroxidation and vitamin E levels in preeclampsia [J].
Kharb, S ;
Gulati, N ;
Singh, V ;
Singh, GP .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 46 (04) :238-240
[9]   Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia [J].
Kupferminc, MJ ;
Peaceman, AM ;
Aderka, D ;
Wallach, D ;
Socol, ML .
OBSTETRICS AND GYNECOLOGY, 1996, 88 (03) :420-427
[10]  
Larsson A, 2003, UPSALA J MED SCI, V108, P51